Literature DB >> 22052458

Update on surgical management of renal cell carcinoma with venous extension.

Javier González1.   

Abstract

Intravenous extension of renal cell carcinoma remains one of the most intense debate topics in urologic oncology. In the absence of effective alternative treatment, complete surgical removal of the primary tumor with its extension along the vena cava is the only hope for a potential cure. For this reason, an aggressive approach has been established as the mainstay of treatment. Recent advances in the understanding of the biology of intravascular tumor invasion and the considerable progress in the fields of diagnosis and treatment of this entity, with innovative surgical and systemic strategies, have completely redefined the management of these patients. A PubMed-MEDLINE search was conducted to identify relevant articles on the preoperative assessment and surgical management of renal cell carcinoma with intravenous tumor extension to provide updated knowledge on this always challenging topic.

Entities:  

Mesh:

Year:  2012        PMID: 22052458     DOI: 10.1007/s11934-011-0222-0

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  46 in total

1.  Cavoatrial tumor thrombectomy with systemic circulatory arrest and antegrade cerebral perfusion.

Authors:  Alessandro Mazzola; Renato Gregorini; Carmine Villani; Laura B Colantonio; Raffaele Giancola; Giovanni L Gravina; Carlo Vicentini
Journal:  Ann Thorac Surg       Date:  2007-04       Impact factor: 4.330

2.  Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.

Authors:  Robert J Motzer; Thomas E Hutson; Piotr Tomczak; M Dror Michaelson; Ronald M Bukowski; Olivier Rixe; Stéphane Oudard; Sylvie Negrier; Cezary Szczylik; Sindy T Kim; Isan Chen; Paul W Bycott; Charles M Baum; Robert A Figlin
Journal:  N Engl J Med       Date:  2007-01-11       Impact factor: 91.245

Review 3.  Robotic surgery and minimally invasive management of renal tumors with vena caval extension.

Authors:  Ronney Abaza
Journal:  Curr Opin Urol       Date:  2011-03       Impact factor: 2.309

4.  Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup.

Authors:  Axel Haferkamp; Patrick J Bastian; Hildegard Jakobi; Maria Pritsch; Jesco Pfitzenmaier; Peter Albers; Peter Hallscheidt; Stefan C Müller; Markus Hohenfellner
Journal:  J Urol       Date:  2007-05       Impact factor: 7.450

Review 5.  Renal artery embolization: clinical indications and experience from over 100 cases.

Authors:  Michael J Schwartz; Eric B Smith; David W Trost; E Darracott Vaughan
Journal:  BJU Int       Date:  2006-12-13       Impact factor: 5.588

Review 6.  Renal cell carcinoma: modern surgical approach.

Authors:  Sidney C Abreu; Inderbir S Gill
Journal:  Curr Opin Urol       Date:  2003-11       Impact factor: 2.309

7.  Surgical management of renal cell carcinoma associated with complex inferior vena caval thrombi.

Authors:  Paul Sweeney; Christopher G Wood; Louis L Pisters; Joel W Slaton; Ara Vaporciyan; Mark Munsell; Scott Carpenter; Joe Putnam; Stephen G Swisher; Garret Walsh; David Swanson; Colin P N Dinney
Journal:  Urol Oncol       Date:  2003 Sep-Oct       Impact factor: 3.498

8.  Results of inferior vena caval interruption by greenfield filter, ligation or resection during radical nephrectomy and tumor thrombectomy.

Authors:  Michael L Blute; Stephen A Boorjian; Bradley C Leibovich; Christine M Lohse; Igor Frank; R Jeffrey Karnes
Journal:  J Urol       Date:  2007-06-11       Impact factor: 7.450

9.  Novel techniques for tumor thrombectomy for renal cell carcinoma with intraatrial tumor thrombus.

Authors:  Ujjwal K Chowdhury; Anand K Mishra; Amlesh Seth; Prem N Dogra; Jayanth H V Honnakere; Ganapathy K Subramaniam; Amber Malhotra; Poonam Malhotra; Neeti Makhija; Panangipalli Venugopal
Journal:  Ann Thorac Surg       Date:  2007-05       Impact factor: 4.330

10.  Renal cell carcinoma clinically involving adjacent organs: experience with aggressive surgical management.

Authors:  Vitaly Margulis; Ricardo F Sánchez-Ortiz; Pheroze Tamboli; Daniel D Cohen; David A Swanson; Christopher G Wood
Journal:  Cancer       Date:  2007-05-15       Impact factor: 6.860

View more
  6 in total

Review 1.  Caval thrombus in conjunction with renal tumors: indication for surgery and technical details.

Authors:  J González; G Ciancio
Journal:  Curr Urol Rep       Date:  2014-11       Impact factor: 3.092

2.  Preoperative hypoalbuminemia and anemia as predictors of transfusion in radical nephrectomy for renal cell carcinoma: a retrospective study.

Authors:  Kyungmi Kim; Hyungseok Seo; Ji-Hyun Chin; Hyo-Jung Son; Jai-Hyun Hwang; Young-Kug Kim
Journal:  BMC Anesthesiol       Date:  2015-07-21       Impact factor: 2.217

3.  Multi-disciplinary surgical approach to the management of patients with renal cell carcinoma with venous tumor thrombus: 15 year experience and lessons learned.

Authors:  Bishoy A Gayed; Ramy Youssef; Oussama Darwish; Payal Kapur; Aditya Bagrodia; James Brugarolas; Ganesh Raj; J Michael DiMaio; Arthur Sagalowsky; Vitaly Margulis
Journal:  BMC Urol       Date:  2016-07-19       Impact factor: 2.264

4.  Synchronous nephrectomy and cavoatrial tumor thrombectomy under normothermic extracorporeal circulation and beating heart.

Authors:  Eleftheria Mavrigiannaki; Ioannis Fesatidis; Evgenia Kalogridaki; Ioannis-Petros Katralis; Dimitrios Filippou; Panagiotis Skandalakis; Dionisios Vrochides
Journal:  J Surg Case Rep       Date:  2018-05-15

Review 5.  [Surgery of inferior vena cava-associated urological tumor lesions].

Authors:  M Weber; F Meyer; U B Liehr; Z Halloul
Journal:  Urologe A       Date:  2013-10       Impact factor: 0.639

6.  A Predictive Model for Tumor Invasion of the Inferior Vena Cava Wall Using Multimodal Imaging in Patients with Renal Cell Carcinoma and Inferior Vena Cava Tumor Thrombus.

Authors:  Zhuo Liu; Liwei Li; Peng Hong; Guodong Zhu; Shiying Tang; Xun Zhao; Qiming Zhang; Guoliang Wang; Wei He; Hua Zhang; Heng Xue; Ligang Cui; Huiyu Ge; Jie Jiang; Shudong Zhang; Fangting Cao; Jing Yan; Fengrong Ma; Cheng Liu; Lulin Ma; Shumin Wang
Journal:  Biomed Res Int       Date:  2020-10-06       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.